Ken Hess

831 total citations
11 papers, 603 citations indexed

About

Ken Hess is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ken Hess has authored 11 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Ken Hess's work include Breast Cancer Treatment Studies (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Neuroblastoma Research and Treatments (2 papers). Ken Hess is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Neuroblastoma Research and Treatments (2 papers). Ken Hess collaborates with scholars based in United States, France and Germany. Ken Hess's co-authors include Alice J. Sigurdson, A Sweeney, Ashraful Hoque, Harold E. B. Humphrey, Keith D. Burau, W. K. Alfred Yung, H. Ian Robins, Larry Junck, Kathleen R. Lamborn and Gabriel N. Hortobágyi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Ken Hess

11 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Hess United States	8	216	172	159	139	122	11	603
Are Helseth Norway	17	66 0.3×	62 0.4×	322 2.0×	223 1.6×	197 1.6×	25	783
Claire Briet France	17	126 0.6×	212 1.2×	123 0.8×	95 0.7×	56 0.5×	53	1.2k
Michael T. Smith United States	14	170 0.8×	69 0.4×	140 0.9×	81 0.6×	192 1.6×	32	688
Yutao Wei China	18	96 0.4×	212 1.2×	106 0.7×	91 0.7×	220 1.8×	40	847
Miia Suuriniemi United States	15	196 0.9×	114 0.7×	55 0.3×	48 0.3×	162 1.3×	18	847
Léa Guerrini‐Rousseau France	13	71 0.3×	97 0.6×	308 1.9×	170 1.2×	79 0.6×	40	585
Marthe Rizk‐Rabin France	18	91 0.4×	171 1.0×	43 0.3×	40 0.3×	105 0.9×	37	828
Yilin Yu China	14	168 0.8×	176 1.0×	49 0.3×	35 0.3×	125 1.0×	49	680
Nicola Chiarelli Italy	22	124 0.6×	59 0.3×	37 0.2×	52 0.4×	96 0.8×	40	1.0k
Anne‐Isabelle Bertozzi France	15	59 0.3×	43 0.3×	411 2.6×	222 1.6×	142 1.2×	29	757

Countries citing papers authored by Ken Hess

Since Specialization

Citations

This map shows the geographic impact of Ken Hess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Hess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Hess more than expected).

Fields of papers citing papers by Ken Hess

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Hess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Hess. The network helps show where Ken Hess may publish in the future.

Co-authorship network of co-authors of Ken Hess

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Hess. A scholar is included among the top collaborators of Ken Hess based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Hess. Ken Hess is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Adrada, Beatriz E., et al.. (2018). Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. American Journal of Roentgenology. 210(4). W173–W179. 42 indexed citations

Fisher, Sarah B., Ken Hess, Travis E. Grotz, et al.. (2017). Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Journal of Surgical Oncology. 117(4). 685–691. 4 indexed citations

Groisberg, Roman, Ken Hess, Siqing Fu, et al.. (2017). Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors. Scientific Reports. 7(1). 15963–15963. 21 indexed citations

Damodaran, Senthil, Ken Hess, Lumarie Santiago, et al.. (2017). Abstract CT062: NCT02456857: A phase II trial of liposomal doxorubicin, bevacizumab and everolimus (DAE) in patients with localized triple-negative breast cancer (TNBC) with tumors predicted insensitive to standard neoadjuvant chemotherapy. Cancer Research. 77(13_Supplement). CT062–CT062. 1 indexed citations

Liedtke, Cornelia, Ken Hess, Thomas Karn, et al.. (2013). The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Research and Treatment. 138(2). 591–599. 70 indexed citations

Delpech, Yann, Ying Wu, Ken Hess, et al.. (2012). Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer. Breast Cancer Research and Treatment. 135(2). 619–627. 28 indexed citations

Phan, Alexandria T., James C. Yao, David R. Fogelman, et al.. (2010). A prospective, multi-institutional phase II study of GW786034 (pazopanib) and depot octreotide (sandostatin LAR) in advanced low-grade neuroendocrine carcinoma (LGNEC).. Journal of Clinical Oncology. 28(15_suppl). 4001–4001. 62 indexed citations

Prados, Michael D., Kathleen R. Lamborn, W. K. Alfred Yung, et al.. (2006). A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study1. Neuro-Oncology. 8(2). 189–193. 187 indexed citations

Yao, J. C., Chaan S. Ng, Ken Hess, et al.. (2005). Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab. Journal of Clinical Oncology. 23(16_suppl). 4007–4007. 41 indexed citations

10.

Hoque, Ashraful, Alice J. Sigurdson, Keith D. Burau, et al.. (1998). Cancer among a Michigan cohort exposed to polybrominated biphenyls in 1973.. PubMed. 9(4). 373–404. 142 indexed citations

11.

Strom, Sara S., Ken Hess, Alice J. Sigurdson, Margaret R. Spitz, & Jan C. Liang. (1997). Evaluation of sister chromatid exchange and chromosome breaks in a cohort of untreated Hodgkin's disease patients.. PubMed. 6(4). 291–3. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact